Kim E. Caramelli

Pharmacokinetics, Efficacy, and Safety of a Permeation-Enhanced Testosterone Transdermal System in Comparison with Bi-Weekly Injections of Testosterone Enanthate for the Treatment of Hypogonadal Men*

Adrian S. Dobs, A.W. Meikle, Stefan Arver et al. · The Journal of Clinical Endocrinology & Metabolism · 1999 · 357 citations

Medicine, Endocrinology, Pharmacology +16

Efficacy and Safety of Oxybutynin Chloride Topical Gel for Overactive Bladder: A Randomized, Double-Blind, Placebo Controlled, Multicenter Study

David Staskin, Roger R. Dmochowski, Peter K. Sand et al. · The Journal of Urology · 2009 · 110 citations

Medicine, Pharmacology, Urology +12

Interrelationships among Lipoprotein Levels, Sex Hormones, Anthropometric Parameters, and Age in Hypogonadal Men Treated for 1 Year with a Permeation-Enhanced Testosterone Transdermal System1

Adrian S. Dobs, Paul S. Bachorik, Stefan Arver et al. · The Journal of Clinical Endocrinology & Metabolism · 2001 · 73 citations · Full text

Medicine, Endocrinology, Andrology +16

Silodosin for Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Results of a Phase II Multicenter, Double-Blind, Placebo Controlled Study

J. Curtis Nickel, Michael P. O’Leary, Herbert Lepor et al. · The Journal of Urology · 2011 · 70 citations

Medicine, Internal Medicine, Pharmacotherapy +13

Clinical experience using the Androderm testosterone transdermal system in hypogonadal adolescents and young men with beta-thalassemia major.

Vincenzo De Sanctis, Cecilia Vullo, Loredana Urso et al. · PubMed · 1998 · 41 citations

Medicine, Endocrinology, Pharmacology +15